Skip to main content
. 2021 Nov 23;11:778858. doi: 10.3389/fonc.2021.778858

Figure 1.

Figure 1

Kaplan-Meier plots illustrating overall survival in metastatic prostate cancer (mPCa) patients (n=2495) prior to propensity score matching (A) and in 2490 mPCa patients after propensity score matching (B), stratified by chemotherapy status.